Genmab — Juli 2022
-
Feedback from our poll overwhelmingly supports the assertion that MM patients can be re-treated with Darzalex, on the assumption that there has been an extended break in exposure to the drug. All 30 specialists said they are comfortable re-treating patients with Darzalex in these circumstances, with 50% of respondents describing themselves as 'very' comfortable with this approach and 37% as 'extremely' comfortable.
-
oncurrently, Darzalex is also being evaluated as a potential maintenance treatment for MM. In the Phase III AURIGA trial, the combination of Darzalex plus Revlimid (lenalidomide) versus Revlimid alone is being studied as maintenance treatment in approximately 214 patients with newly diagnosed MM who are MRD positive following high-dose therapy (HDT) and autologous stem cell transplant (ASCT).
-
-
Det er vist heller ikke sukkeralf, der udstikker strategien .... det er JnJ og den er ikke baseret på håb
-
De fleste analytikere tror, at olien (brent) generelt holder sig over 100 dollar resten af 2022.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind